Verition Fund Management’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.06M | Buy |
94,154
+100
| +0.1% | +$1.13K | ﹤0.01% | 1818 |
|
|
2025
Q1 | $536K | Buy |
94,054
+63,527
| +208% | +$362K | ﹤0.01% | 1951 |
|
|
2024
Q4 | $300K | Sell |
30,527
-66,673
| -69% | -$655K | ﹤0.01% | 2147 |
|
|
2024
Q3 | $792K | Buy |
+97,200
| New | +$792K | ﹤0.01% | 1452 |
|
|
2023
Q4 | – | Sell |
-3,398
| Closed | -$246K | – | 1963 |
|
|
2023
Q3 | $246K | Buy |
3,398
+2,385
| +235% | +$173K | ﹤0.01% | 1524 |
|
|
2023
Q2 | $75.3K | Buy |
1,013
+578
| +133% | +$43K | ﹤0.01% | 1725 |
|
|
2023
Q1 | $23.1K | Sell |
435
-692
| -61% | -$36.8K | ﹤0.01% | 1828 |
|
|
2022
Q4 | $76.2K | Sell |
1,127
-132
| -10% | -$8.92K | ﹤0.01% | 1459 |
|
|
2022
Q3 | $157K | Buy |
1,259
+75
| +6% | +$9.35K | ﹤0.01% | 1946 |
|
|
2022
Q2 | $113K | Buy |
1,184
+219
| +23% | +$20.9K | ﹤0.01% | 1964 |
|
|
2022
Q1 | $155K | Buy |
965
+215
| +29% | +$34.5K | ﹤0.01% | 1598 |
|
|
2021
Q4 | $249K | Hold |
750
| – | – | ﹤0.01% | 1461 |
|
|
2021
Q3 | $348K | Buy |
+750
| New | +$348K | ﹤0.01% | 1152 |
|